search
Back to results

Male Circumcision and HIV Rates in Kenya

Primary Purpose

HIV Infections

Status
Completed
Phase
Phase 3
Locations
Kenya
Study Type
Interventional
Intervention
male circumcision
Sponsored by
National Institute of Allergy and Infectious Diseases (NIAID)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV Infections focused on measuring Male circumcision, HIV acquisition, Sexually transmitted infection, HIV Seronegativity

Eligibility Criteria

18 Years - 24 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria HIV uninfected and willing to be tested Live in Kisumu District, Kenya Uncircumcised but willing to be circumcised At least one sexual partner in the 12 months prior to study entry

Sites / Locations

  • UNIM Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Circumcised immediately

Delayed Circumcision

Arm Description

Men who were randomized to delayed circumcision were scheduled to be offered male circumcision 2 years after their randomization.

Outcomes

Primary Outcome Measures

HIV incidence
surgical complications

Secondary Outcome Measures

incidence of other sexually transmitted diseases
behavioral risks

Full Information

First Posted
April 23, 2003
Last Updated
May 28, 2008
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
search

1. Study Identification

Unique Protocol Identification Number
NCT00059371
Brief Title
Male Circumcision and HIV Rates in Kenya
Official Title
Trial of Male Circumcision to Reduce HIV Incidence
Study Type
Interventional

2. Study Status

Record Verification Date
September 2007
Overall Recruitment Status
Completed
Study Start Date
February 2002 (undefined)
Primary Completion Date
October 2006 (Actual)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The Luo tribe of Kisumu, Kenya, does not traditionally practice male circumcision (MC). This study will work with the Luo tribe to test the effectiveness of MC on reducing the risk of HIV infections in young men.
Detailed Description
Since 1989, numerous epidemiological studies have reported a significant association between lack of male circumcision (MC) and risk for HIV infection through heterosexual intercourse. These results have led to calls for male circumcision to be considered as an additional HIV prevention strategy. However, there is a consensus among the international health community that a randomized controlled trial of MC is needed to control for possible confounding factors. Additionally, known risks associated with MC need further investigation. This study will assess the effectiveness of male circumcision in reducing HIV incidence and will evaluate complications of the MC procedure, changes in sexual behavior following circumcision, and the biological mechanisms by which the foreskin may increase HIV susceptibility. The study will be conducted in Kisumu, Kenya, where the Luo tribe is the main ethnic group and less than 10% of adult men are circumcised. Uncircumcised men aged 18 to 24 years old will be offered voluntary HIV counseling and testing. HIV negative men will be asked to enroll in the study. All study participants will be interviewed to obtain socio-demographic information and assess behavioral risk factors. Participants will be examined for significant medical conditions. All men will be counseled in strategies to reduce their risk for HIV infection. Consenting men will be randomly assigned to either the treatment (circumcised) arm or the control (uncircumcised) arm of the study. After circumcision, men will be monitored for complications. They will be counseled to abstain from sex until healing is complete. Follow-up visits will occur every 6 months for 2 years. Uncircumcised men will be offered circumcision at the end of follow-up. The primary study endpoints will be HIV incidence and surgical complications. Additional outcomes will be the incidence of other sexually transmitted diseases and behavioral risks. Additional laboratory studies of foreskin tissue will evaluate the number and density of specialized cells rich in HIV receptors in order to illuminate the biological mechanisms by which presence of foreskin may increase HIV susceptibility.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
Male circumcision, HIV acquisition, Sexually transmitted infection, HIV Seronegativity

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2887 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Circumcised immediately
Arm Type
Active Comparator
Arm Title
Delayed Circumcision
Arm Type
Placebo Comparator
Arm Description
Men who were randomized to delayed circumcision were scheduled to be offered male circumcision 2 years after their randomization.
Intervention Type
Procedure
Intervention Name(s)
male circumcision
Primary Outcome Measure Information:
Title
HIV incidence
Time Frame
2 years
Title
surgical complications
Time Frame
2 years
Secondary Outcome Measure Information:
Title
incidence of other sexually transmitted diseases
Time Frame
2 years
Title
behavioral risks
Time Frame
2 years

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria HIV uninfected and willing to be tested Live in Kisumu District, Kenya Uncircumcised but willing to be circumcised At least one sexual partner in the 12 months prior to study entry
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert C. Bailey, PhD, MPH
Organizational Affiliation
University of Illinois at Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNIM Clinic
City
Kisumu
Country
Kenya

12. IPD Sharing Statement

Citations:
PubMed Identifier
30055581
Citation
Davis SM, Pals S, Yang C, Odoyo-June E, Chang J, Walters MS, Jaoko W, Bock N, Westerman L, Toledo C, Bailey RC. Circumcision status at HIV infection is not associated with plasma viral load in men: analysis of specimens from a randomized controlled trial. BMC Infect Dis. 2018 Jul 28;18(1):350. doi: 10.1186/s12879-018-3257-8.
Results Reference
derived
PubMed Identifier
22421693
Citation
Mehta SD, Gaydos C, Maclean I, Odoyo-June E, Moses S, Agunda L, Quinn N, Bailey RC. The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex Transm Dis. 2012 Apr;39(4):276-80. doi: 10.1097/OLQ.0b013e318240189c.
Results Reference
derived
PubMed Identifier
21606224
Citation
Mehta SD, Maclean I, Ndinya-Achola JO, Moses S, Martin I, Ronald A, Agunda L, Murugu R, Bailey RC, Melendez J, Zenilman JM. Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009. Antimicrob Agents Chemother. 2011 Aug;55(8):3882-8. doi: 10.1128/AAC.00155-11. Epub 2011 May 23.
Results Reference
derived
PubMed Identifier
19571722
Citation
Mehta SD, Gray RH, Auvert B, Moses S, Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS. 2009 Jul 31;23(12):1557-64. doi: 10.1097/QAD.0b013e32832afe95.
Results Reference
derived
PubMed Identifier
17321310
Citation
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643-56. doi: 10.1016/S0140-6736(07)60312-2.
Results Reference
derived

Learn more about this trial

Male Circumcision and HIV Rates in Kenya

We'll reach out to this number within 24 hrs